Is POTS an Autoimmune Disease?

“Is POTS autoimmune?” is one of those questions you start asking once you have been living with it for a while. The condition often turns up after a viral illness, runs more often in women, and overlaps with several diseases that are clearly autoimmune. So it would make a certain kind of sense if the immune system were involved. But the research has not landed there yet, and the honest answer is more interesting than a yes or no.

This is a plain-language walk through what the autoimmune hypothesis for POTS actually means, what evidence supports it, and what is still uncertain — written for people who want to understand their own body, not for the textbooks.

What “autoimmune” actually means

An autoimmune disease is one in which the immune system mistakenly attacks the body’s own tissues. The classic examples — type 1 diabetes, rheumatoid arthritis, lupus, multiple sclerosis — all share that pattern, even though the tissue under attack and the symptoms look very different. Researchers identify a disease as autoimmune when they can repeatedly find specific antibodies or immune cells attacking specific parts of the body, and when treating that immune activity changes the disease.

By that definition, POTS is not currently classified as autoimmune. It is classified as a form of autonomic dysfunction — the nervous system that controls automatic things like heart rate and blood pressure isn’t working the way it should when you stand up. But “not currently classified” is not the same as “settled.” The autoimmune question is one of the most active areas of POTS research right now, and several lines of evidence keep pulling it back into the conversation.

Why so many people suspect autoimmunity

Living with POTS, you pick up on patterns that look immune-flavoured.

It often starts after an infection. Many people can name the week. A bad flu, COVID, mononucleosis, a stomach bug. The post-viral pattern is one of the most consistent observations in POTS, and post-viral onset is also how some clearly autoimmune diseases begin. Whatever the immune system was doing during the infection seems, in some people, to leave something behind.

It is much more common in women. About four in five people with POTS are women, often diagnosed in their teens, twenties, or thirties. That female-skewed pattern is a strong feature of most autoimmune diseases too. The reasons are still being studied, but the overlap is striking enough that it is hard to ignore.

It shows up alongside autoimmune diseases more often than chance would predict. People with POTS have higher rates of conditions like Hashimoto’s thyroiditis, Sjögren’s, celiac disease, and lupus than the general population. Whether POTS shares a root cause with these or is just kept company by them is part of the open question.

What the studies have actually found

The most interesting findings come from a line of research looking at antibodies that target the very receptors involved in autonomic control. These are called G-protein-coupled receptors, and they sit on the cells that respond to signals telling blood vessels to tighten, heart rate to slow, and so on. A subset of people with POTS appear to have antibodies that bind to these receptors — adrenergic and muscarinic ones, in particular.

If that holds up, it would mean that the immune system in some POTS patients is interfering with the very switches the autonomic nervous system uses to regulate standing. That is a plausible mechanism for at least some of the symptoms. But there are real caveats.

The antibody findings have been hard to replicate consistently across labs, partly because the techniques used to measure these antibodies vary. Not every person with POTS has them. People without POTS sometimes do. And finding an antibody is not the same as proving it causes the disease. Researchers describe this evidence as suggestive rather than confirmed.

There is also some interest in inflammatory markers, mast cell involvement, and the more general idea that POTS may not be one condition at all but several different conditions that look alike at the surface. That last possibility may be the most important. Different people’s POTS may have different roots: some viral and immune-driven, some hypovolemic, some related to connective tissue, some still unexplained.

Why it would matter if it were autoimmune

This is not a hypothetical question for people living with the condition. If a person’s POTS has an immune component, that opens specific treatment doors that otherwise stay closed. Things like immunoglobulin therapy or other immune-modulating approaches have been tried in selected patients with severe, treatment-resistant POTS, sometimes with reported benefit, sometimes not. These are not standard treatments and they carry their own risks and burdens. Decisions about them belong with a clinician who specialises in autonomic disorders, not in an article on the internet.

But the framing also matters in less dramatic ways. Patients told their condition is “just anxiety” or “deconditioning” for years often find that even partial validation — “we think your immune system may be part of this” — changes how they advocate for themselves and how clinicians take the case.

What is reasonable to say right now

So is POTS autoimmune? The most honest current answer is: it can be, in at least some people, and the evidence pointing toward immune involvement is genuine but not yet conclusive. POTS as a whole is still classified as an autonomic disorder, but researchers increasingly suspect that a meaningful subset of cases has an autoimmune flavour — particularly those with a clear post-viral onset and those that don’t respond to standard approaches.

If you are trying to figure out what camp you fall into, that is a conversation for a clinician who actually works with autonomic disorders. A primary care doctor, however lovely, will rarely have the context. Specialists in this space tend to think about POTS in subtypes, take post-viral onset seriously, and know which tests and treatments are worth exploring versus skipping.

A small note for foggy days

If you came to this article hoping for a clean yes or no, I’m sorry the answer is “we’re still working it out.” But “we’re still working it out” is also good news. It means people in labs and clinics are taking the question seriously, and that the field is moving. The version of POTS care that exists in ten years is likely to look quite different from the version that exists now, and the autoimmune question is one of the threads that may pull the rest along with it. In the meantime, your body is doing something real, and the right framing for it is being figured out — even if it is taking longer than any of us would like.